Crofelemer

What is Crofelemer?

• Crofelemer (Mytesi) is an anti-diarrheal used to treat noninfectious diarrhea in HIV positive patients on antiretroviral therapy.
• Crofelemer is an antidiarrheal agent derived from the red sap of the South American plant Croton lechleri.

File:Crofelemer.svg

Crofelemer

File:Crofelemer skeletal.svg

Crofelemer skeletal

What are the uses of this medicine?

• This medicine is used for symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.

How does this medicine work?

• Crofelemer (kroe fel' e mer) is a botanical antidiarrheal agent that is used to treat noninfectious diarrhea in HIV seropositive patients taking antiretroviral medications.
• Crofelemer is derived from the red sap of the South American plant Croton lechleri, which has been used for centuries to treat diarrheal illness.
• The active antidiarrheal product in crofelemer appears to be a large macromolecular, oligomeric proanthocyanidin which has been shown to decrease chloride secretion in the intestine by inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR), as well as calcium-activated chloride channels.
• In large clinical trials, daily therapy with crofelemer was found to decrease watery bowel movements and improve stool consistency in patients with HIV infection receiving antiretroviral therapy, and who had persistent diarrhea that could not be attributed to an infectious cause.

Who Should Not Use this medicine ?

• This medicine have no usage limitations.

What drug interactions can this medicine cause?

• Mytesi administration did not have any clinically relevant interaction with nelfinavir, zidovudine, or lamivudine in a drug-drug interaction trial.

Is this medicine FDA approved?

• Crofelemer was approved for use in the United States in 2012, the first herbal medication to be approved for a specific medical use and first agent approved for therapy of noninfectious diarrhea in HIV positive patients.

How should this medicine be used?

• Before starting Mytesi, rule out infectious etiologies of diarrhea.

Recommended dosage:

• The recommended adult dosage is 125 mg taken orally twice a day, with or without food.

Administration:

• Do not crush or chew Mytesi tablets.
• Swallow whole.

What are the dosage forms and brand names of this medicine?

This medicine is available in fallowing doasage form:

• As Delayed-Release Tablets: 125 mg

This medicine is available in fallowing brand namesː

• Mytesi

What side effects can this medication cause?

The most common side effects of this medicine include:

• upper respiratory tract infection
• bronchitis
• cough
• flatulence
• increased bilirubin

What special precautions should I follow?

• Before starting Mytesi, rule out infectious etiologies of diarrhea. Mytesi is not indicated for the treatment of infectious diarrhea.
• Instruct patients that Mytesi tablets may be taken with or without food.
• Instruct patients to swallow Mytesi tablets whole and not to crush or chew the tablets.

What to do in case of emergency/overdose?

• In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.

• Overdose related information is also available online at poisonhelp.org/help.
• In the event that the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services. In the United States, call 911.

Can this medicine be used in pregnancy?

• Crofelemer is minimally absorbed systemically by the oral route of administration and maternal use is not expected to result in fetal exposure to the drug

Can this medicine be used in children?

• The safety and effectiveness of Mytesi have not been established in pediatric patients.

What are the active and inactive ingredients in this medicine?

Active ingredient: CROFELEMER

• Inactive ingredients:

CELLULOSE, MICROCRYSTALLINE CROSCARMELLOSE SODIUM SILICON DIOXIDE MAGNESIUM STEARATE ETHYL ACRYLATE TALC TRIETHYL CITRATE XANTHAN GUM TITANIUM DIOXIDE PROPYLPARABEN METHYLPARABEN

Who manufactures and distributes this medicine?

• Manufactured by Patheon, Inc. for

Napo Pharmaceuticals, Inc., San Francisco, CA

What should I know about storage and disposal of this medication?

• Store at 20°C-25°C (68°F-77°F); excursions permitted between 15°C-30°C (59°F-86°F).

• Dailymed label info on Crofelemer
• FDA Crofelemer